← 產業報告目錄
NeuN Antibody Market Size, Share & Trends Analysis Report By Type (Polyclonal & Monoclonal), By Application (Immunocytochemistry, Immunofluorescence, Immunohistochemistry, Western Blot & Others), By Region, And By Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-09頁數 170報告編號 INSIGHTACE-6ce30185df
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The NeuN Antibody Market on a global scale was estimated at USD 39.7 Mn in 2023 and is projected to attain USD 167.8 Mn by 2031, with a projected CAGR of 20.4% between 2024 and 2031.
At its core, NeuN Antibody pertains to The NeuN antibody represents an essential instrument in neuroscience research for the precise identification of fully developed neurons in the central nervous system (CNS). Stakeholders across the healthcare landscape are escalatingly turning to these solutions to meet contemporary demands.
The market's upward path is fueled by escalating healthcare spending, technological evolution, and the escalating focus on personalized and precision-based approaches in healthcare.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
From a regional perspective, mature markets in North America and Europe continue to hold pronounced shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and escalating investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global NeuN Antibody Market Snapshot
Chapter 4. Global NeuN Antibody Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type Estimates & Trend Analysis
5.1. by Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type:
5.2.1. Polyclonal
5.2.2. Monoclonal
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
6.2.1. Immunocytochemistry
6.2.2. Immunofluorescence
6.2.3. Immunohistochemistry
6.2.4. Western Blot
6.2.5. Others
Chapter 7. NeuN Antibody Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America NeuN Antibody Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
7.1.2. North America NeuN Antibody Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
7.1.3. North America NeuN Antibody Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
7.2. Europe
7.2.1. Europe NeuN Antibody Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
7.2.2. Europe NeuN Antibody Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
7.2.3. Europe NeuN Antibody Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
7.3. Asia Pacific
7.3.1. Asia Pacific NeuN Antibody Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
7.3.2. Asia Pacific NeuN Antibody Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
7.3.3. Asia Pacific NeuN Antibody Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
7.4. Latin America
7.4.1. Latin America NeuN Antibody Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
7.4.2. Latin America NeuN Antibody Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
7.4.3. Latin America NeuN Antibody Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
7.5. Middle East & Africa
7.5.1. Middle East & Africa NeuN Antibody Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
7.5.2. Middle East & Africa NeuN Antibody Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
7.5.3. Middle East & Africa NeuN Antibody Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Boster Biological Technology
8.2.2. Thermo Fisher Scientific
8.2.3. Abcam
8.2.4. HUABIO
8.2.5. Synaptic
8.2.6. GeneTex
8.2.7. BioLegend
8.2.8. Merck
8.2.9. NSJ Bioreagents
8.2.10. Bioss
8.2.11. Miltenyi Biotec
8.2.12. United States Biological
8.2.13. Proteintech
8.2.14. FineTest
8.2.15. Cell Signaling Technology
8.2.16. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們